Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, 2025 ...

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

Symphony’s services reduce the travel burden for patients which broadens ICON’s recruitable population, providing patients access to clinical research studies that they may not have otherwise ...

DUBLIN, July 10, 2024--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a ...

Clinical-trial operator Icon PLCICLR-0.78%decrease; red down pointing triangle said it would acquire rival PRA Health Sciences Inc. for $12 billion, creating a powerhouse provider of services to ...

As the most advanced healthcare intelligence and clinical research organisation in the industry, ICON will utilise the funding to further invest in the build-out of its world-class technology and ...